The U.S. government will stop distributing free doses of Merck & Co's (MRK.N) COVID-19 antiviral treatment molnupiravir...
Read More
The Centre has approved investment of Rs 6000 crore to 74 industries in the pharmaceutical and medical device...
Read More
Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.'s Upjohn unit in 2020, has sold two of its...
Read More
The World Health Organization (WHO) on Monday recommended a new malaria vaccine, R21/Matrix-M, to curb the...
Read More
Generic drugmakers may have been lauded for making drugs affordable, across the world. But its not time to rest on...
Read More
An antibiotic already in use in Europe to treat pneumonia controlled deadly bloodstream infections with Staphylococcus...
Read More
Indian pharmaceutical companies like Cipla and Sun Pharma can boost their global role by improving product registration,...
Read More
Japan's Eisai (4523.T) said its Alzheimer's treatment developed with Biogen (BIIB.O), Leqembi, was approved by the...
Read More
The U.S. Centers for Disease Control and Prevention (CDC) on backed Pfizer's respiratory syncytial virus (RSV) vaccine...
Read More
Drugmaker Glenmark Pharmaceuticals Ltd said it would sell a 75% stake in Glenmark Life Sciences Ltd to Nirma Ltd for Rs...
Read More
In this strategic acquisition, AHH is investing Rs 600 crore through a combination of primary and secondary funding....
Read More
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said it has received approval from an independent...
Read More